Injective Advances US Regulatory Efforts for Tokenized Securities
Injective is making regulatory progress in the US for tokenized securities and institutional blockchain finance.
Injective is making regulatory progress in the US for tokenized securities and institutional blockchain finance. Injective (INJ) is trading at ₹719 ($7.57), down 0.8% since this brief published. This is an original Token Times brief based on reporting by CaptainAltcoin, with live market data added, as of Sat, 24 Oct 2026 14:45:01 UTC.
This development is significant as it positions Injective to potentially bridge decentralized finance with traditional financial markets in the US, subject to regulatory approval. The meetings signal a strategic push towards institutional adoption of blockchain-based financial products.
- Injective held high-level meetings with US regulatory bodies including the SEC and CFTC.
- The discussions focused on tokenized securities and institutional blockchain finance.
- INJ token is down 3.92% in the last 24 hours amid broader market decline.
- Injective Token Surges 25% in a Week Amid US Regulatory Talks and Institutional Interest
- Injective Partners with BDACS for Won-Backed Tokenized Asset Settlement
- Injective Advances US Regulatory Efforts for Tokenized Securities — this brief
Injective, a blockchain platform focused on decentralized finance, has taken a significant step forward in its US regulatory strategy by engaging with key government agencies.
The company recently conducted meetings in Washington with officials from the White House, SEC, and CFTC. These discussions were attended by CEO Eric Chen and members of Injective's legal, policy, and research teams.
While the exact outcomes of the meetings remain undisclosed, the engagement indicates Injective's commitment to navigating the complex regulatory landscape for tokenized securities and institutional blockchain applications in the US.
The development comes amid a broader market downturn, with the total crypto market cap at $2.77 trillion and 
Bitcoin experiencing a 1.51% decline over the past 24 hours.
Injective's native token INJ is currently priced at $7.63, having fallen 3.92% in the last day and 11.64% over the past week. The token has a market cap of $763.36 million.
Since this brief published about 59 minutes ago, Injective (INJ) has moved from ₹725.13$7.63 to ₹719.43$7.57 — -0.79%.
The chart plots INJ's price: grey is the move before this brief published, the vertical dashed line marks the moment it published, the horizontal dashed line is the price then, and the coloured area is the move since — from Token Times's market data (daily resolution; intraday detail builds over the first day). It shows what happened after the news, not that the news caused it; many factors move prices. Not financial advice.
At today's peer-to-peer rate, 1 INJ ≈ ₹788.76 (about $7.57), down 4.0% over 24 hours. The rupee itself trades about 9.6% above the official rate on the P2P market, so a Indian buyer's effective cost differs from the headline dollar price.
Live market data
Current prices for the asset in this story — live, source-stamped, updated every 15 minutes.
Figures and sectors in this story, checked live against on-chain aggregators · October 24, 2026.
Token Times reads these figures directly from on-chain aggregators (DeFiLlama, mempool.space) at build time — independent of what any outlet reported. Sector totals aggregate every protocol DeFiLlama tracks in that category. Values are live and will change.
Injective Advances US Regulatory Efforts for Tokenized Secur — questions & answers
What regulatory agencies did Injective meet with?
Injective met with officials from the White House, SEC, and CFTC.
Why are these meetings important for Injective?
The meetings are crucial for gaining regulatory clarity and paving the way for Injective's expansion into tokenized securities and institutional blockchain finance in the US.
How has the INJ token performed recently?
The INJ token is down 3.92% in the last 24 hours and 11.64% over the past week.
How much is 1 Injective worth in rupee today?
About ₹788.76 at the live peer-to-peer (P2P) USDT rate, which is what Indians typically trade at — equivalent to roughly $7.57. The rupee price moves with both INJ's US-dollar price and the USDT/INR rate; use our Injective in rupee page for any amount.
Has Injective's price moved since this brief was published?
INJ is down 0.79% since this brief first published — trading at ₹719 ($7.57) now versus ₹725 ($7.63) at publication. Token Times re-checks this figure against CoinGecko and Binance every 15 minutes.
Which outlets reported this story?
This is an original Token Times brief that synthesises reporting from CaptainAltcoin. It is not a copy of any one article — follow the source links above for the original reporting.
Original summary — not financial advice. This is an original Token Times brief that summarises a development reported elsewhere and adds live market data for context; it is not the original article and reproduces no part of it. Follow the source link above for full details. Crypto is volatile and high-risk — always do your own research.